The survival analysis indicated that high PTTG1 expression was significantly associated with poor DMFS in all breast cancer patients, and in the luminal A and B subtypes, which implies that PTTG1 might play an oncogenic role in breast cancer. This evidence concerns the gene PTTG1 and breast carcinoma.